O]H 2 O positron-emission tomography was performed to quantify resting MBF, hyperemic MBF, and coronary flow reserve. Left ventricular dimensions, function, and scar burden were assessed with cardiovascular magnetic resonance imaging. An electrophysiological study was performed to test VA inducibility. Positive electrophysiological study patients (n=12) showed reduced hyperemic MBF (1.25±0.30 versus 1.66±0.38 mL•min 
S udden cardiac death (SCD) attributable to ventricular arrhythmia (VA) is a feared complication of ischemic cardiomyopathy. 1 Large clinical trials have shown that the implantable cardioverter defibrillator (ICD) therapy significantly reduced mortality in patients with cardiomyopathy. 2, 3 As a result, current guidelines recommend ICD implantation for primary prevention of SCD in patients with left ventricular ejection fraction (LVEF) <35%. 4 It has become increasingly clear, however, that selection of patients eligible for ICD therapy solely based on impaired LVEF is suboptimal because a substantial number of patients with ICD never receive appropriate therapy. 5 Therefore, improved risk stratification for VA is essential to identify patients most likely to benefit from ICD implantation.
Clinical Perspective on p 30
Myocardial perfusion abnormalities may serve as an important substrate for VA because they result in dispersion of repolarization leading to electric instability. [6] [7] [8] Impaired hyperemic myocardial blood flow (MBF) and coronary flow reserve (CFR) as assessed with positron-emission tomography (PET) are powerful independent risk factors for cardiac death not only in patients with ischemic but also in idiopathic dilated and hypertrophic cardiomyopathy. [9] [10] [11] [12] [13] Life-threatening
Background-Risk stratification for ventricular arrhythmias (VAs) is important to refine selection criteria for primary prevention implantable cardioverter defibrillator therapy. Impaired hyperemic myocardial blood flow (MBF) is associated with increased mortality rate in ischemic and nonischemic cardiomyopathy, which may be attributed to electric instability inducing VAs. The aim of this pilot study was to assess whether hyperemic MBF impairment may be related with VA inducibility in patients with ischemic cardiomyopathy. Methods and Results-Thirty patients with ischemic cardiomyopathy referred for primary prevention implantable cardioverter defibrillator implantation were prospectively included (26 men; 65±8 years old; left ventricular ejection fraction, 29±6%). [ arrhythmias are an important and common cause of death in these classifications of cardiomyopathy, suggesting that quantitative assessment of MBF could be used not merely for risk stratification but specifically to identify patients prone to SCD. 14 The link between the occurrence of VA and impaired myocardial perfusion, however, remains to be elucidated.
The aim of this pilot study was to assess whether hyperemic MBF and CFR as assessed with [ 15 O]H 2 O PET are associated with VA inducibility during an electrophysiological study (EPS) in patients with ischemic cardiomyopathy. Furthermore, the role of alternative risk factors such as LVEF, scar size, transmurality, and border zone as assessed with cardiovascular magnetic resonance (CMR) imaging was evaluated.
Methods

Study Population
Patients with ischemic cardiomyopathy and LVEF ≤35%, who were referred for ICD implantation for primary prevention of SCD based on current guidelines, 4 were prospectively included. Exclusion criteria were a cardiac rhythm other than sinus rhythm and a previous history of sustained VA. During the study period, 581 ICD devices were implanted, of which 316 devices were combined with resynchronization therapy or implanted for secondary prevention indication. Of the remaining 265 patients, 109 had nonischemic cardiomyopathy, and another 19 patients did not have sinus rhythm. Of the remaining 137 eligible patients, 107 patients could not be included because of refusal of participation, logistical issues, or other contraindications for PET, CMR, or EPS. A total of 30 patients were included in the described study. None of the patients displayed residual ischemia at noninvasive testing amendable to revascularization before referral for ICD implantation. All patients underwent CMR, PET, and EPS for research purposes after inclusion in this study. The study was approved by the Ethics Committee of the VU University Medical Center, in accordance with the Declaration of Helsinki, and written informed consent was obtained from all patients.
CMR Image Acquisition
CMR studies were performed on a clinical 1.5-T MRI scanner (Magnetom Avanto; Siemens, Erlangen, Germany) using a dedicated phased-array body coil. After survey scans, cine imaging was performed using a retrospectively ECG-gated, steady-state free precession sequence during breath holds of ≈10 seconds in mild expiration (typical image parameters: slice thickness, 5 mm; slice gap, 5 mm; temporal resolution<50 ms; repetition time, 3.2 ms; echo time, 1.54 ms; flip angle, 60°; typical image resolution 1.3×1.6×5.0 mm). Standard 4-, 3-, and 2-chamber orientations were obtained, and, subsequently, a stack of 10 to 12 consecutive short-axis slices was acquired, fully covering the LV from the mitral valve annulus to the apex. After administration of 0.2 mmol.kg −1 gadolinium-DOTA (Dotarem, Guerbet, Villepinte, France) and a delay of 10 to 15 minutes, late gadolinium enhancement (LGE) images were acquired in similar orientations as the cine images, using a 2-dimensional segmented inversion-recovery-prepared gradient echo sequence (echo time, 4.4 ms; repetition time, 9.8 ms; inversion time, 250-300 ms; typical voxel size, 1.3×1.6×5.0 mm). In case of difficulties with breath holding during LGE imaging, a single-shot sequence was used instead of a segmented sequence.
CMR Image Analysis
Images were analyzed using the software package MASS (Mass v.5.1 2010-EXP beta, Medis, Leiden, The Netherlands). Endocardial and epicardial borders of short-axis cine images were outlined manually in both end-diastolic and end-systolic phases. Papillary muscles were included in the LV cavity. LV volumes, LVEF, and mass were computed using these analyses. Subsequently, endocardial and epicardial contours of the short-axis LGE images were traced manually. Myocardial scar size was quantified using the full width at half-maximum method, which defines scar as myocardial tissue with a signal intensity ≥50% of the maximum signal intensity in hyperenhanced area. 15 Scar border zone was defined as myocardium with signal intensity ≥35% but <50% of the maximum signal intensity as previously described. 16 Scar and scar border zone were automatically quantified, and manual adjustments of the automated tracings were made when necessary. Areas of enhancement were quantified by computer-assisted planimetry on each of the short-axis images based on the 17-segment American Heart Association (AHA) model, 17 excluding the apex. Total scar size and border zone were expressed as grams and percentages of the total LV mass. Furthermore, the transmural extent of LGE was quantified by dividing scar transmurality into quartiles (1% to 25%, 25% to 50%, 50% to 75%, and 75% to 100%). 18 Mean infarct transmural extent was calculated as the mean transmurality of all myocardial scar segments. According to segmental enhancement results, scar segments and normal remote segments were selected.
PET Image Acquisition
All PET studies were performed using a PET/computed tomography (CT) device (Philips Gemini TF 64, Philips Healthcare, Best, The Netherlands). Patients were instructed to refrain from intake of products containing caffeine or xanthine 24 hours before the scan. The scanning protocol consisted of a 6-minute emission scan, which was started simultaneously with the injection of a 5 mL (0. . This dynamic scan sequence was followed immediately by a respiration-averaged low dose CT scan to correct for attenuation (55 mAs; rotation time, 1.5 s; pitch, 0.825; collimation, 64×0.625; acquiring 20 cm in 11 s) during normal breathing. 19 After an interval of 10 minutes to allow for decay of radioactivity, an identical PET sequence was performed 2 minutes after the start of intravenous adenosine infusion (140 µg•kg
). Adenosine infusion was terminated after the low-dose CT. Dynamic images were reconstructed into 22 frames (1×10, 8×5, 4×10, 2×15, 3×20, 2×30, and 2×60 seconds) using the 3-dimensional row-action maximum likelihood algorithm and applying all appropriate corrections.
PET Image Analysis
PET image analysis was performed using in-house developed software. 20 Image-derived input functions of the ascending aorta and right ventricular cavity were obtained by manually defining volumes of interest during the first pass phase of the injected tracer bolus. Both volumes of interest were then transferred to the full dynamic images to obtain arterial whole blood and right ventricular time-activity curves. Parametric images of MBF, perfusable tissue fraction, and arterial and venous blood volume fractions were generated as previously described. 20 Parametric images of arterial and venous blood volume fractions were subtracted from normalized CT transmission images, resulting in parametric anatomic tissue fraction images. 21 Finally, volumes of interest were defined manually on short-axis parametric perfusable tissue fraction images, according to the 17-segment AHA model 17 after which this template was projected onto the parametric MBF images. MBF was expressed in millilitres per minute per gram of perfusable tissue. CFR was defined as the ratio of hyperemic and resting MBF. Based on scar and remote segments selected in the LGE-CMR image analysis, mean resting MBF, hyperemic MBF, and CFR in scar and remote areas were assessed. Heterogeneity of MBF and CFR was expressed as the coefficient of variation (COV), which was calculated as the ratio of the standard deviation and the mean of myocardial segments (excluding the apex) multiplied by 100 for global myocardium, scar, and remote areas.
Electrophysiological Study
After ICD implantation, an EPS was performed noninvasively using the ICD and its programmer. The EPS protocol consisted of programmed stimulation delivered from the right ventricular lead with 8-beat drive trains (2 cycle lengths of 600 and 400 ms) immediately followed by up to 3 extrastimuli. Extrastimuli were delivered at progressively shorter coupling intervals in 20-ms steps until the effective refractory period was reached. No coupling interval shorter than 180 ms was used. If no sustained VA was induced, the protocol was repeated with a basic cycle length of 400 ms under infusion of isoproterenol (aimed baseline heart rate 100-110/min). 22, 23 The EPS was performed and interpreted by an experienced electrophysiologist blinded to the imaging data. In case a monomorphic VA was induced, the origin was determined based on the 12-lead ECG by 2 independent electrophysiologists blinded to the imaging data. A positive EPS was defined as ventricular fibrillation or ventricular tachycardia lasting >30 seconds or requiring termination in case of hemodynamic instability.
Statistical Analysis
Continuous variables are presented as mean±SD, and categorical data are summarized as frequencies and percentages. The Shapiro-Wilk test and histograms were used to evaluate whether continuous data were normally distributed. Groups with positive and negative EPS were compared using the unpaired 2-sided Student t test for continuous variables and 2-tailed Fisher exact test for categorical data. Levene test for equality of variances was used to verify whether the equal variances assumption of the unpaired Student t test was appropriate. Comparison of normally distributed paired data was performed with the paired t test. If not stated otherwise, nonparametric tests confirmed the parametric test results and were not needed. Receiver-operating characteristic (ROC) curve analysis was used for all imaging variables, and areas under the curve (AUCs) were calculated. Patients with missing values for resting MBF (n=1) and scar size (n=1) were excluded from the ROC-curve analysis to allow adequate comparisons of AUCs. Furthermore, univariate logistic regression analysis was performed for clinical and global imaging variables. Odds ratios (ORs) were determined per 0.1 U decrease for MBF and CFR and per 1 U increase for COV. A P value <0.05 was considered statistically significant. All statistical analyses were performed using SPSS software package (SPSS 20.0, IBM Corporation, Armonk, NY) and MedCalc (MedCalc 12.7.0, MedCalc Software, Oostende, Belgium).
Results
Study Population
Thirty patients were included in this study. Clinical baseline characteristics are presented in Table 1 . None of the patients were considered candidates for revascularization before inclusion in this study. In 27 of 30 patients, coronary angiography was performed within a median time of 8 (IQR 2-21) months. In 21 patients, complete revascularization was achieved, whereas in 6 patients, residual lesions persisted not amendable to revascularization because noninvasive conventional perfusion imaging revealed no signs of significant ischemia. In all 3 patients without coronary angiography, no ischemia was detected at noninvasive testing. Patients with residual coronary lesions (but without clinical significant ischemia) were more likely to have a positive EPS (P=0.06). All patients underwent CMR and [
15 O] H 2 O PET after inclusion in this study. In 1 patient, LGE was not assessed because of severe motion artifacts, whereas in another individual, resting MBF could not be obtained because of technical problems. Twelve patients (40%) displayed VA inducibility at EPS (monomorphic VA n=11, polymorphic VA n=1). The origin of the induced monomorphic VAs was determined in 10 patients (anteroseptal wall n=3, lateral wall n=3, inferior wall n=4), whereas in 1 patient, the origin was indeterminate because of poor quality of the ECG. There were no significant differences in clinical baseline characteristics between patients with a positive and a negative EPS. However, a trend was observed toward a higher prevalence of diabetes mellitus in the EPS positive Figure 1 . Positron-emission tomography (PET) and cardiovascular magnetic resonance (CMR) scan in 2 patients with a history of an anterior wall myocardial infarction. In patient 1 (A-D), electrophysiological study (EPS) was negative, whereas in patient 2 (E-H), a monomorphic ventricular tachycardia was induced. Both patients displayed significant scar size (C, D, G, and H) and perfusion defect (A, B, E, and  F) in the anteroseptal wall. Quantitative myocardial blood flow (MBF) results showed significantly impaired hyperemic MBF in patient 2 as compared with patient 1. Note the difference in scaling on the PET images (A, B, E, and F) between both patients.
group. Figure 1 provides examples of PET and CMR images of patients with positive and negative EPS.
Cardiovascular Magnetic Resonance
Results of CMR imaging are presented in Table 2 and Figure 2 . Mean LVEF was 28.9±6.1%. There were no significant differences in LV volumes or LVEF between patients with positive and negative EPS. Mean scar size was 15.8±9.1% with a mean transmural extent of 34.6±16.5%. There were no differences observed in scar size and border zone between both patient groups. Patients with a positive EPS, however, displayed a higher number of segments with >75% scar transmurality, whereas the number of segments with 1% to 25% transmurality was higher in patients with negative EPS. In total, 8 of 10 induced monomorphic VAs originated from scar areas, which were transmurally infarcted in 4 patients. , P=0.11, respectively). These results for hyperemic MBF and CFR were comparable within scar and remote areas. As demonstrated in Figure 3 , there was no significant difference in global resting MBF between patients with positive and negative EPS (P=0.85). However, patients with positive EPS were characterized by a significantly impaired global hyperemic MBF (P=0.004) resulting in a significantly reduced global CFR compared with patients with EPS negative (P=0.009). Comparable results were obtained for both hyperemic MBF and CFR in scar and remote areas compared between both groups ( 16±0.45, P=0.02, respectively) . Again, these results were comparable for scar areas as well as remote areas. Results for the COV of MBF data are presented in Table 4 and Figure 4 . Scar areas were characterized by a higher COV of resting and hyperemic MBF in comparison with remote areas. Patients with VA inducibility during EPS displayed significantly higher COV of resting MBF, hyperemic MBF, and CFR in global myocardium. These differences were predominantly driven by higher COVs in the infarct area. The origin of induced monomorphic VAs displayed a mean hyperemic MBF and CFR of 0.94±0.61 mL•min −1
Positron-Emission Tomography
•g −1 and 1.35±0.73, respectively. In 6 patients with a positive EPS, the origin of VA displayed hyperemic MBF<1.00 mL•min
whereas the CFR was <2.00 in 8 patients. Figure 5 ), whereas scar size, infarct transmurality, and border zone were not. For global hyperemic MBF, an optimal derived cutoff value of 1.66 mL•min −1
Risk Factors for VA Inducibility
•g −1 yielded a sensitivity of 100 and specificity of 56%. Optimal cutoff value for global CFR was 1.80, with a sensitivity of 80 and specificity of 72%. Comparable results were observed for the AUCs of hyperemic MBF and CFR in scar and remote areas (Table 5 ). AUCs for COV of MBF and CFR in different areas ranged from 0.58 for resting MBF in remote area to 0.83 for CFR in scar area. 
Discussion
The aim of the current pilot study was to evaluate whether impaired hyperemic MBF and CFR were associated with VA inducibility in patients with ischemic cardiomyopathy and to compare the role of alternative imaging variables such as scar size, transmurality, and border zone. Global hyperemic MBF and CFR were found to be significantly lower in patients with a positive EPS. Of interest, this pattern was observed in both the scar area and the remote myocardium. In contrast to quantitative myocardial perfusion imaging, scar size, border zone, and LVEF did not differ between patients with positive and negative EPS. However, patients with positive EPS displayed a higher number of scar segments with >75% transmurality.
Refinement of eligibility criteria for primary prevention ICD therapy is needed as LVEF has limited sensitivity for predicting the risk of SCD. 24 Currently, much effort is put into the search for enhanced risk stratification markers, which assess the pathophysiological substrate related to electric instability. 25 Among parameters such as scar burden 16, [26] [27] [28] [29] [30] [31] [32] and sympathetic innervation defects, 33 ischemia might play an important role. Myocardial perfusion abnormalities resulting in ischemia are well known to modulate automaticity, excitability, and refractoriness. These changes lead to heterogeneity of repolarization, thus creating a substrate for VA. 34 , 35 Paganelli et al 36 demonstrated that residual ischemia in patients after a myocardial infarction, assessed with single photon emission computed tomographic, was associated with inducibility of VA, whereas LVEF and fixed perfusion defects were not. In particular, the extent of residual ischemia in the peri-infarction area was found to be of importance. To determine whether single photon emission computed tomographic imaging might improve risk stratification for SCD, Piccini ) and coronary flow reserve (CFR) based on total n=29 with positive electrophysiological study (EPS) n=11. PET indicates positron-emission tomography.
et al 37 performed a study of >6000 patients with coronary artery disease with a median follow-up time of 2.7 years. The summed stress perfusion defect score was an independent risk factor for SCD and provided incremental prognostic value over LVEF. Interestingly, both summed difference perfusion defect score (reflecting ischemia) and resting perfusion defect score (reflecting scar) were not associated with SCD in a multivariate analysis, suggesting that the combination of scar and ischemia has incremental prognostic value compared with both single imaging variables. Furthermore, in patients with coronary artery disease and LVEF>35%, similar results were obtained. 38 Hyperemic perfusion abnormalities, reflecting scarred, hibernating, and ischemic myocardium, might therefore assist in risk stratification for VA in patients with impaired and preserved LVEF.
Because ischemia serves as an important trigger or substrate for VA, current guidelines recommend optimal revascularization in case of residual ischemia before ICD therapy. 4 Yet in a not inconsequential number of patients, (subtle) perfusion abnormalities persist, which are not amendable to revascularization, as demonstrated in the current study. In comparison with single photon emission computed tomographic imaging, PET myocardial perfusion imaging has a higher resolution and allows for absolute quantification of perfusion. 39, 40 Consequently, more subtle perfusion abnormalities can be detected in patients with ischemic and nonischemic cardiomyopathy. Assessment of quantitative hyperemic MBF and CFR might, therefore, enhance risk stratification. Indeed, several large studies have demonstrated the incremental prognostic value of hyperemic MBF and CFR as assessed with PET in patients with ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and hypertrophic cardiomyopathy. [9] [10] [11] [12] [13] Tio et al 9 investigated the prognostic value of CFR assessed with PET in comparison with LVEF in patients with ischemic cardiomyopathy. Global CFR was an independent strong risk factor for total cardiac mortality. Consistent with the results of Piccini et al, 37 these findings were superior to the prognostic value of LVEF and independent of the extent of qualitatively assessed ischemia or scar size. The question arises, however, whether the value of impaired quantitatively assessed hyperemic MBF and CFR in risk stratification holds true for VAs specifically. In the current study, VA inducibility was related with impaired Mean COV of resting MBF and CFR based on total n=29 with positive EPS n=11. CFR indicates coronary flow reserve; COV, coefficient of variation; EPS, electrophysiological study; and MBF, myocardial blood flow (mL•min
. 43, 44 MBF specifically within the infarcted area was assessed. We found that both resting and hyperemic MBF were significantly lower in scar segments compared with remote areas reflecting lower metabolic demand and coronary microvascular dysfunction in the peri-infarct myocardium.
Global MBF in patients with ischemic cardiomyopathy consists of a combination of perfusion in scar areas, residual ischemic areas, and remote areas. Consequently, heterogeneity of perfusion and CFR is present, which may contribute to the heterogeneity of repolarization and enhanced vulnerability for VA. Therefore, the COVs of MBF and CFR in global myocardium, scar areas, and remote areas were calculated. Indeed, the COV of resting MBF, hyperemic MBF, and CFR were related with VA inducibility, in particular within scar regions. An alternative explanation might be from a methodological point of view. Dense scar segments often have poor count statistics and spillover artifacts, resulting in nonphysiological MBF readings. These technical factors may also explain the COV findings. However, patients with a positive EPS displayed a higher COV in remote areas as well, in particular for CFR. Nonetheless, the specific assessment of MBF impairment and heterogeneity in scar areas yielded no incremental value compared with global hyperemic MBF.
Interestingly, total scar size and infarct border zone did not identify patients prone to VA inducibility in the current study. These results are inconsistent with previously published larger studies demonstrating the value of CMR-assessed infarct size 45 and border zone 46 in predicting the risk of VA inducibility. More importantly, the role of scar burden in risk stratification for spontaneous VA events was demonstrated in ischemic and nonischemic cardiomyopathy. [26] [27] [28] [29] [30] 32 In the present study, the difference in scar size between EPS negative and positive patients did not reach statistical significance. This might be because of the smaller sample size included in this study as compared with the abovementioned larger studies. Patients with a positive EPS, however, displayed a higher number of transmural scar segments with >75% transmurality. This resembles the findings in the study performed by Scott et al, 32 which demonstrated that the number of myocardial segments with full-thickness (>75% transmurality) scar was the most important risk factor for appropriate ICD therapy. However, in the current study, scar transmurality was not associated with VA inducibility in univariate analysis. Next to scar burden, CMR assessment of infarct border zone specifically may improve risk stratification for VA events. 16, 31, 46 The value of infarct border zone, however, is less well established because several studies use different definitions for the quantification of infarct tissue heterogeneity, which are not interchangeable. 27 In the current study, the definition described by Roes et al 16 was used for border zone quantification because this method minimizes the susceptibility to border zone overestimation and excludes the potential influence of suboptimal T1 nulling and artifacts in the remote myocardium affecting the signal intensity. Patients with a positive EPS did not display a larger infarct border zone. This may be because we assessed the relation with VA inducibility, whereas Roes et al 16 demonstrated the value in risk stratification for spontaneous VA events.
Limitations
There are several limitations in this study. First, we evaluated the myocardial electric instability with EPS. Although previous studies have demonstrated that a positive EPS in the chronic phase after myocardial infarction is the single best risk factor for the occurrence of spontaneous VA, 47, 48 the diagnostic accuracy for clinical events (of SCD) remains only moderate. It is important to note that the value of VA inducibility in risk stratification for SCD depends on the type of stimulation protocol used and the type of initiated VA during EPS. 49 Induction of a monomorphic VA has been demonstrated to be more relevant than polymorphic VA or ventricular fibrillation. 50, 51 In 11 of 12 patients with a positive EPS result in our study, a monomorphic VA was induced. Second, this study population comprised a small number of patients, therefore potentially obscuring some associated imaging variables, which did not reach statistical significance. Furthermore, multivariable analysis including potential confounders such as the somewhat skewed distribution of patients with DM between the EPS positive and negative groups in the current study could not be performed because of the small sample size. Indeed, it has been demonstrated that patients with coronary risk factors such as diabetes mellitus are more likely to have impaired hyperemic MBF. 52 However, no differences were observed in hyperemic MBF between patients with and without diabetes in the current study. Moreover, comparable differences in hyperemic MBF and CFR between EPS positive and negative patients were obtained when excluding patients with diabetes mellitus. Finally, the ROC analysis used in this study is not a robust method for the evaluation of risk predictors for VA inducibility. 53 Therefore, the results of this study should be interpreted in a descriptive manner. Studies in a larger number of patients with appropriately timed follow-up collecting more relevant clinical end points are warranted.
Conclusion
In this pilot study, impaired global hyperemic MBF and CFR were associated with inducibility of VA in patients with ischemic cardiomyopathy, whereas the relation with CMR-assessed LVEF, scar burden, and border zone seemed of less significance. These results suggest that impaired hyperemic MBF might contribute to electric instability and is hypothesis generating for the potential role of quantitative PET myocardial perfusion imaging in risk stratification for VAs in patients with ischemic cardiomyopathy.
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